TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 18785525

Group type: EXPERIMENTAL
Intervention: Bryan cervical disc replacement
Number of subjects: 59

Group type: COMPARATOR
Intervention: ACDF (anterior cervical discectomy and fusion)
Number of subjects: 59
Study: 16469021

Group type: EXPERIMENTAL
Intervention: Adjustable bulbourethral sling (Argus)
Number of subjects: 48
Study: 14528481

Group type: EXPERIMENTAL
Intervention: Conservative management (expectant or medical treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transvaginal sonography
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Understanding serum human chorionic gonadotropin change and low serum progesterone levels
Number of subjects: 0
Study: 10102976

Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg
Number of subjects: 609

Group type: COMPARATOR
Intervention: Omeprazole 10 mg
Number of subjects: 609
Study: 7555986

Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB) at 40 mg/kg/day, increased to 60 and 80 mg/kg/day if seizures persisted
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Vigabatrin (VGB)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 1983701

Group type: EXPERIMENTAL
Intervention: Five anxiolytic benzodiazepines taken nocte for 7 days
Number of subjects: 28
Study: 7028299

Group type: EXPERIMENTAL
Intervention: Aluminium phosphate-adsorbed cholera vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aluminium phosphate-adsorbed tetanus toxoid (placebo)
Number of subjects: 0
Study: 31462185

Group type: EXPERIMENTAL
Intervention: Zika virus (ZIKV) IgM
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Zika virus (ZIKV) IgG
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Zika virus (ZIKV) IgM or IgG or both
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Malaria
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Malaria and ZIKV IgM, IgG or both
Number of subjects: 100
Study: 31290176

Group type: EXPERIMENTAL
Intervention: 20-G fine-needle biopsy (FNB)
Number of subjects: 125
Study: 28669488

Group type: EXPERIMENTAL
Intervention: Discharge Hyponatremia (Na <135 meq/L)
Number of subjects: 306

Group type: COMPARATOR
Intervention: Normal Sodium on Discharge
Number of subjects: 306
Study: 25368103

Group type: EXPERIMENTAL
Intervention: Modified radical hysterectomy
Number of subjects: 240
Study: 23818295

Group type: EXPERIMENTAL
Intervention: Protocol based therapy (antibiotic regimens for eradication of newly identified Pseudomonas)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Standard of care (historical controls from 1995 to 1998)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Protocol based therapy
Number of subjects: 304

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 304
Study: 21256809

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b (10 million units flat dose subcutaneously 5 days per week for 4 weeks, then 10 million units flat dose subcutaneously 3 days per week for 12 months) - Group B
Number of subjects: 855

Group type: EXPERIMENTAL
Intervention: Interferon alfa-2b (10 million units flat dose subcutaneously 5 days per week for 1 month, then 10 million units flat dose subcutaneously 3 days per week for 24 months) - Group C
Number of subjects: 855

Group type: COMPARATOR
Intervention: Observation only - Group A
Number of subjects: 855
Study: 19486349

Group type: EXPERIMENTAL
Intervention: Current drinkers
Number of subjects: 32347

Group type: EXPERIMENTAL
Intervention: Past drinkers
Number of subjects: 32347

Group type: EXPERIMENTAL
Intervention: Alcohol intake frequency and duration
Number of subjects: 32347
Study: 17057382

Group type: EXPERIMENTAL
Intervention: levodopa
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo pill
Number of subjects: 0

Group type: COMPARATOR
Intervention: sham TMS
Number of subjects: 0
Study: 14691389

Group type: EXPERIMENTAL
Intervention: Ethanol (0.4 g/kg every 4 hr in 200 ml of orange juice)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Orange juice without ethanol
Number of subjects: 50
Study: 11154618

Group type: EXPERIMENTAL
Intervention: 50 mg Ginkgo biloba extract LI 1370 three times daily for 12 weeks
Number of subjects: 1121

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1121
Study: 9884858

Group type: EXPERIMENTAL
Intervention: remifentanil 1 microgram kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: remifentanil 1 microgram kg‐1 and lignocaine 1 mg kg‐1
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: remifentanil 2 micrograms kg‐1
Number of subjects: 60
Study: 7926537

Group type: EXPERIMENTAL
Intervention: Percutaneous endoscopic gastrostomy (PEG) procedure
Number of subjects: 68
Study: 2744770

Group type: EXPERIMENTAL
Intervention: Blocked highlighting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Random highlighting
Number of subjects: 0

Group type: COMPARATOR
Intervention: No highlighting
Number of subjects: 0
Study: 1111453

Group type: EXPERIMENTAL
Intervention: Intravenous clindamycin phosphate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methicillin
Number of subjects: 0
Study: 7031847

Group type: EXPERIMENTAL
Intervention: 50 mg trimipramine at night
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 30608175

Group type: EXPERIMENTAL
Intervention: Neck Balance System (NBS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Neck Balance System (NBS) + Lumbar Support (LS)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lumbar Support (LS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No Devices (ND)
Number of subjects: 20
Study: 29729518

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Black Carbon (BC)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Interaction of PA and BC
Number of subjects: 122

Group type: COMPARATOR
Intervention: Physical Activity (PA) and Black Carbon (BC)
Number of subjects: 122
Study: 26321238

Group type: EXPERIMENTAL
Intervention: CRT‐On
Number of subjects: 614

Group type: COMPARATOR
Intervention: CRT‐Off
Number of subjects: 614
Study: 25533977

Group type: EXPERIMENTAL
Intervention: Cage implantation in intervertebral space (Group A)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Autogenous morselized bone (Group B)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Cage implantation (Group A)
Number of subjects: 87
Study: 22265034

Group type: EXPERIMENTAL
Intervention: Pre-emptive ibuprofen (400 mg)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 19938164

Group type: EXPERIMENTAL
Intervention: PD SAFEx (exercise program with increased attention to sensory feedback)
Number of subjects: 0

Group type: COMPARATOR
Intervention: non‐SAFE control group (exercise program without increased attention to sensory feedback)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups (PD SAFEx and non‐SAFE)
Number of subjects: 0
Study: 17983800

Group type: EXPERIMENTAL
Intervention: Entecavir 0.5 mg
Number of subjects: 709

Group type: COMPARATOR
Intervention: Lamivudine 100 mg
Number of subjects: 709
Study: 15837968

Group type: COMPARATOR
Intervention: ABVD chemotherapy (doxorubicin, bleomycin, vinblastine, and dacarbazine)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Radiation therapy (subtotal nodal radiation for favorable risk or combined-modality therapy for unfavorable risk)
Number of subjects: 399

Group type: EXPERIMENTAL
Intervention: Combined-modality treatment (for unfavorable risk patients)
Number of subjects: 399
Study: 12495553

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba capsules (120 mg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ginkgold (reference product)
Number of subjects: 0
Study: 9872352

Group type: EXPERIMENTAL
Intervention: Benfotiamine
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Combination of benfotiamine and vitamins B6 and B12
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 7759675

Group type: EXPERIMENTAL
Intervention: Culturally sensitive interventions based on a framework of eight dimensions (language, persons, metaphors, content, concepts, goals, methods, and context)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Culturally sensitive perspective to treatment outcome research
Number of subjects: 0
Study: 2240721

Group type: EXPERIMENTAL
Intervention: Medtronic Activitrax pacemakers with intra- and inter-flight threshold re-programming and external magnet application
Number of subjects: 4
Study: 380718

Group type: EXPERIMENTAL
Intervention: Polyglycolic acid 3/0
Number of subjects: 48

Group type: COMPARATOR
Intervention: Chromic catgut 3/0
Number of subjects: 48
Study: 31833168

Group type: EXPERIMENTAL
Intervention: PCT-guided strategy (n = 370)
Number of subjects: 742

Group type: COMPARATOR
Intervention: Standard care (n = 372)
Number of subjects: 742

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 742
Study: 29785857

Group type: EXPERIMENTAL
Intervention: Visual Structured Criterion (VSC)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ALIV (Actual and Linearly Interpolated Values)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Binomial test
Number of subjects: 0
Study: 28747453

Group type: EXPERIMENTAL
Intervention: Serum MMP-9 levels
Number of subjects: 3186
Study: 24698216

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 23941739

Group type: EXPERIMENTAL
Intervention: Adaptive servoventilation (ASV)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 51
Study: 21040937

Group type: EXPERIMENTAL
Intervention: High-fat diet
Number of subjects: 6

Group type: COMPARATOR
Intervention: Well-balanced diet
Number of subjects: 6
Study: 19253122

Group type: EXPERIMENTAL
Intervention: 5 mg desloratadine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18046976

Group type: EXPERIMENTAL
Intervention: zofenopril 30-60 mg once daily
Number of subjects: 304

Group type: COMPARATOR
Intervention: atenolol 50-100 mg once daily
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: zofenopril
Number of subjects: 304

Group type: COMPARATOR
Intervention: atenolol
Number of subjects: 304
Study: 15037401

Group type: EXPERIMENTAL
Intervention: Single blastocyst transfer
Number of subjects: 48

Group type: COMPARATOR
Intervention: Two blastocysts transfer
Number of subjects: 48
Study: 11400817

Group type: EXPERIMENTAL
Intervention: 10 microg recombinant vaccine intramuscularly (IM)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: 2 microg recombinant vaccine intradermally (ID)
Number of subjects: 165
Study: 9171806

Group type: EXPERIMENTAL
Intervention: Integrated treatment
Number of subjects: 217

Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 217
Study: 8350215

Group type: COMPARATOR
Intervention: High-dose steroids
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Elemental diet
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: High-dose steroids and Elemental diet
Number of subjects: 24
Study: 3538789

Group type: EXPERIMENTAL
Intervention: Nimodipine
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study: 28704308

Group type: EXPERIMENTAL
Intervention: Tournament Games (TG)
Number of subjects: 10

Group type: COMPARATOR
Intervention: League Games (LG)
Number of subjects: 10
Study: 27711915

Group type: EXPERIMENTAL
Intervention: Primary Furlow palatoplasty
Number of subjects: 20

Group type: COMPARATOR
Intervention: Secondary Furlow palatoplasty
Number of subjects: 20
Study: 26676737

Group type: EXPERIMENTAL
Intervention: One-year vocational retraining program
Number of subjects: 1028

Group type: COMPARATOR
Intervention: Two-year vocational retraining program
Number of subjects: 1028
Study: 22382923

Group type: EXPERIMENTAL
Intervention: Instruction on ICMJE authorship criteria
Number of subjects: 203

Group type: COMPARATOR
Intervention: No instruction on ICMJE authorship criteria
Number of subjects: 203
Study: 21665534

Group type: EXPERIMENTAL
Intervention: Anodal tDCS (active comparator)
Number of subjects: 10

Group type: COMPARATOR
Intervention: tRNS
Number of subjects: 10

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 10
Study: 18437071

Group type: EXPERIMENTAL
Intervention: Self-care interventions
Number of subjects: 21
Study: 16530757

Group type: EXPERIMENTAL
Intervention: Sildenafil citrate (viagra) 100 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 14530679

Group type: EXPERIMENTAL
Intervention: Ligasure
Number of subjects: 34

Group type: COMPARATOR
Intervention: Conventional diathermy
Number of subjects: 34
Study: 10764172

Group type: EXPERIMENTAL
Intervention: Intrathecal 0.5 mg morphine (Group IT0.5)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intrathecal 0.1 mg morphine (Group IT0.1)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intravenous 10 mg morphine (Group IV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Inhalation anesthesia alone (Group C)
Number of subjects: 40
Study: 8844444

Group type: EXPERIMENTAL
Intervention: VX-366 (1, 7, 14 or 28 grams or approximately 14, 100, 200 or 400 mg/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: VX-366 (100 to 150 mg/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 1393470

Group type: EXPERIMENTAL
Intervention: Bag method
Number of subjects: 20

Group type: COMPARATOR
Intervention: Rack method
Number of subjects: 20
Study: 6190318

Group type: EXPERIMENTAL
Intervention: simultaneous radio-chemotherapy
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: early second-look operation
Number of subjects: 55
Study: 31358145

Group type: EXPERIMENTAL
Intervention: mSCUBA technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Peripheral blunt dissection technique
Number of subjects: 20
Study: 28320978

Group type: EXPERIMENTAL
Intervention: Participatory workplace improvement (PWI) based ergonomic training sessions provided to on-site managers (3 sessions with 1-month intervals) and ergonomic action checklists (ACLs).
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 0
Study: 25300916

Group type: EXPERIMENTAL
Intervention: Virtual reality-based buffet restaurant intervention
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Predictors of calories chosen for girls' meals
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Predictors of calories chosen for boys' meals
Number of subjects: 221
Study: 23558909

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (GDT) with continuous monitoring of stroke volume variation (SVV) and stroke volume (SV) using FloTrac/Vigileo, receiving 1,589 ml of colloids during surgery.
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (GDT) with continuous monitoring of stroke volume variation (SVV) and stroke volume (SV) using FloTrac/Vigileo, SVV decreased from 9.0 to 8.0 % during surgery.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (CON) receiving 927 ml of colloids during surgery.
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Goal-directed therapy (GDT)
Number of subjects: 64
Study: 22011394

Group type: EXPERIMENTAL
Intervention: e-referral system for smoking cessation
Number of subjects: 2
Study: 19793161

Group type: EXPERIMENTAL
Intervention: Multicomponent cognitive behavioral group intervention (8 weekly sessions + 1 booster session)
Number of subjects: 540
Study: 16393262

Group type: EXPERIMENTAL
Intervention: Cold dry air (CDA)
Number of subjects: 41
Study: 14700554

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) replacement for 12 months
Number of subjects: 24

Group type: COMPARATOR
Intervention: Baseline evaluation
Number of subjects: 24
Study: 11504771

Group type: EXPERIMENTAL
Intervention: N-(4-hydroxyphenyl)retinamide (4-HPR)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 8500244

Group type: EXPERIMENTAL
Intervention: Hydralazine plus isosorbide dinitrate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2964253

Group type: EXPERIMENTAL
Intervention: Amlodipine (2.5-10 mg daily, titrated at 2 weekly intervals for 8 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Amlodipine (10 mg daily)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Amlodipine (various doses)
Number of subjects: 30
Study: 30608742

Group type: EXPERIMENTAL
Intervention: Magic-Intensity Optical Dipole Trap (MI-ODT) array
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Single MI-ODT
Number of subjects: 16
Study: 27370308

Group type: EXPERIMENTAL
Intervention: STARR with curved alone stapler (CAS group)
Number of subjects: 254

Group type: COMPARATOR
Intervention: STARR with combined use of linear and curved staplers (LCS group)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Both procedures
Number of subjects: 254
Study: 25907985

Group type: EXPERIMENTAL
Intervention: Lifestyle Intervention (LSI)
Number of subjects: 601

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 601
Study: 23975134

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicines for nourishing yin, supplementing qi, and activating blood combined with hydroxychloroquine sulfate tablets
Number of subjects: 66

Group type: COMPARATOR
Intervention: Hydroxychloroquine sulfate tablets
Number of subjects: 66
Study: 20500279

Group type: EXPERIMENTAL
Intervention: One-month hospital-based clinic intervention
Number of subjects: 157

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 157
Study: 18955424

Group type: EXPERIMENTAL
Intervention: Kinaesthetic ability training device in addition to a conventional rehabilitation programme for four weeks, five days a week
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional rehabilitation programme
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Kinaesthetic ability training device
Number of subjects: 30
Study: 16651294

Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Incubator care
Number of subjects: 28
Study: 12535040

Group type: EXPERIMENTAL
Intervention: Propofol infusion anaesthesia (3 mg x kg‐1 induction, 20, 15 and 10 mg x kg‐1 x h‐1 maintenance)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Thiopenthal induction (5 mg x kg‐1) followed by halothane maintenance (2-3%)
Number of subjects: 36
Study: 10377733

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy for chronic HBV hepatitis: 5 MU thrice weekly for 6 months
Number of subjects: 1122

Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy for chronic hepatitis C: protocols changed over time from 3 x 3 MU for 6 months to 3 x 3 MU for 12 months, including combination with ribavirin
Number of subjects: 1122
Study: 9193433

Group type: EXPERIMENTAL
Intervention: Early ramipril (10 mg)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Low-dose ramipril (0.625 mg)
Number of subjects: 352

Group type: EXPERIMENTAL
Intervention: Delayed ramipril (10 mg, day 14)
Number of subjects: 352

Group type: COMPARATOR
Intervention: Both ramipril groups
Number of subjects: 352
Study: 7681899

Group type: EXPERIMENTAL
Intervention: Diltiazem controlled release (b.i.d.)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard diltiazem (t.i.d. or q.i.d.)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 49
Study: 3959968

Group type: EXPERIMENTAL
Intervention: 2 mg buprenorphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 4 mg buprenorphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abrupt cessation of buprenorphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reintroduction of buprenorphine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Urine assay for opiate drugs
Number of subjects: 0
Study: 31164431

Group type: EXPERIMENTAL
Intervention: Pirfenidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29248266

Group type: EXPERIMENTAL
Intervention: PCV7
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PCV7 and PCV13
Number of subjects: 0
Study: 26490132

Group type: EXPERIMENTAL
Intervention: Pre-SCPC HCAZ
Number of subjects: 230

Group type: EXPERIMENTAL
Intervention: HCAZ increase from enrollment to pre-SCPC
Number of subjects: 230

Group type: COMPARATOR
Intervention: Asymmetric growth indices
Number of subjects: 230
Study: 24947255

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus lomustine and SOC (third line and beyond)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus lomustine and then placebo plus SOC
Number of subjects: 0
Study: 22516850

Group type: EXPERIMENTAL
Intervention: Yi Ren Medical Qigong (YRMQ)
Number of subjects: 32
Study: 19818957

Group type: EXPERIMENTAL
Intervention: Unipedicular Kyphoplasty (KP)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Bipedicular Kyphoplasty (KP)
Number of subjects: 58
Study: 18499299

Group type: EXPERIMENTAL
Intervention: Computer-based dermatology tutorial (Group 1)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Traditional lecture on skin morphology (Group 2)
Number of subjects: 73
Study: 15977464

Group type: EXPERIMENTAL
Intervention: Risedronate 5 mg daily
Number of subjects: 3331
Study: 12707876

Group type: EXPERIMENTAL
Intervention: Pelvic floor exercises (PFXs)
Number of subjects: 720
Study: 11279974

Group type: EXPERIMENTAL
Intervention: Histamine (0.1 to 1 ng, subcutaneous administration, twice a week for 12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (subcutaneous administration, twice a week for 12 weeks)
Number of subjects: 60
Study: 9546933

Group type: EXPERIMENTAL
Intervention: Regression equations for predicting claudication pain distances based on ABI, body mass index, gender, and smoking status.
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Self-reported distances to onset and maximal claudication pain.
Number of subjects: 272
Study: 1578306

Group type: EXPERIMENTAL
Intervention: Alternate-day corticosteroid therapy
Number of subjects: 35

Group type: COMPARATOR
Intervention: Daily corticosteroid regimen
Number of subjects: 35

Group type: COMPARATOR
Intervention: Daily corticosteroid regimen (after switching to alternate-day therapy)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Alternate-day corticosteroid therapy (continued from the outset)
Number of subjects: 35
Study: 2859648

Group type: EXPERIMENTAL
Intervention: Blockade of histamine receptors with Fenistil plus Tagamet
Number of subjects: 2250